|
|
Volumn 16, Issue 3, 2002, Pages 407-413
|
|
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): An open-label pilot study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APC 2059;
TRYPTASE INHIBITOR;
UNCLASSIFIED DRUG;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BLEEDING;
CLINICAL TRIAL;
DISEASE ACTIVITY;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
ECCHYMOSIS;
ENDOSCOPY;
ERYTHEMA;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
NEUROLOGIC DISEASE;
PHASE 2 CLINICAL TRIAL;
PILOT STUDY;
PRIORITY JOURNAL;
REMISSION;
SCORING SYSTEM;
TREATMENT OUTCOME;
ULCERATIVE COLITIS;
VERTIGO;
ADULT;
AGED;
COLITIS, ULCERATIVE;
FEMALE;
HUMANS;
INFLAMMATION MEDIATORS;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
SERINE ENDOPEPTIDASES;
SERINE PROTEINASE INHIBITORS;
TRYPTASES;
|
|
EID: 0036188833
PISSN: 02692813
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2036.2002.01194.x Document Type: Article |
|
Times cited : (90)
|
|
References (17)
|
